Chart

Repligen Corp

RGEN

Jan 1 1970 00:00:00

121.76

▲0.7000▲0.58%

Open119.20

High122.31

Low118.01

Close121.06

Volume41.14k

EPS

0.87

P/E

139.95

Market Cap

6.86B

Outstanding Shares

56.33M

Soon

Sentiment

Soon

Options

Recent Filings

ID: 0001193125-26-093379

ID: 0001193125-26-093368

ID: 0001193125-26-087669

ID: 0001193125-26-087595

ID: 0001193125-26-087591

ID: 0001193125-26-087579

ID: 0001193125-26-087568

ID: 0001193125-26-087447

ID: 0001193125-26-076528

ID: 0001193125-26-065246

You might find these companies interesting

Century Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Ginkgo Bioworks Holdings, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Biological Products, (No Diagnostic Substances) (2836)

Estrella Immunopharma, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Instil Bio, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Abpro Holdings, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Metagenomi Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Aptose Biosciences Inc.

Biological Products, (No Diagnostic Substances) (2836)

Silexion Therapeutics Corp

Biological Products, (No Diagnostic Substances) (2836)

C4 Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Biological Products, (No Diagnostic Substances) (2836)

4d Molecular Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Cassava Sciences Inc

Pharmaceutical Preparations (2834)

Rapport Therapeutics, Inc.

Pharmaceutical Preparations (2834)